What does Pro Medicus focus on?

Pro Medicus specialises in radiology software solutions that help hospitals and healthcare providers manage and interpret medical imaging.

What products does James Hardie offer?

James Hardie is known for fibre cement and gypsum-based building materials used across residential and commercial construction.

Are PME and JHX part of the ASX 200?

Yes, both Pro Medicus and James Hardie Industries are listed in the ASX 200 index, reflecting their market capitalisation and relevance in their sectors.

PME and JHX Shares: Insights on Two ASX 200 Companies Making Headlines

3 min read | August 08, 2025 04:44 PM AEST | By Team Kalkine Media

Google News:

PME and JHX Shares: Insights on Two ASX 200 Companies Making Headlines — Image source: Shutterstock

Exploring PME and JHX in the ASX 200 Landscape

Two companies that continue to draw attention on the ASX 200 index are Pro Medicus Ltd (PME) and James Hardie Industries plc (JHX). Their unique positions in the healthcare technology and construction materials sectors, respectively, offer a closer look at business models driven by innovation and global demand.

Pro Medicus (ASX:PME): Redefining Radiology Technology

Pro Medicus is known for its cutting-edge radiology IT solutions tailored for hospitals, imaging centres, and healthcare networks worldwide. At the core of its offering is the Visage imaging platform, which supports radiologists in accessing and interpreting high-resolution medical images across various devices.

The company’s software suite supports radiology departments through key systems such as PACS and RIS, enabling streamlined operations from scheduling to diagnosis. The mobile-friendly, cloud-based design facilitates timely clinical decisions and remote collaboration.

These digital tools not only address the increasing need for efficiency in healthcare but also align with trends in remote diagnostics and telehealth, making PME a notable name in medical software.

James Hardie Industries (ASX:JHX): Building Materials with Endurance

James Hardie Industries is a global player in the production of fibre cement and gypsum-based building materials. Operating in several major regions, including North America and Australasia, the company supports the construction sector with solutions valued for their resilience.

Fibre cement cladding, a key offering, is sought for its resistance to fire, water damage, and pests. These attributes make it suitable for both residential and commercial builds that demand long-term durability with minimal upkeep.

JHX's strong manufacturing footprint and established market presence position it as a consistent contributor to global construction trends, especially as sustainability and low-maintenance materials gain traction.

Looking at PME and JHX Through a Broader Lens

Both companies highlight different facets of innovation—PME in medical imaging and JHX in material science. While one enables faster diagnostic decisions, the other empowers more resilient structures. Their performance and presence on the ASX 200 index reflect investor confidence in sectors essential to modern living: healthcare and housing.

Whether it's technological evolution or material sustainability, PME and JHX show how specialised solutions can drive global reach and operational focus in their respective industries.

Frequently Asked Questions

What does Pro Medicus focus on?
Pro Medicus specialises in radiology software solutions that help hospitals and healthcare providers manage and interpret medical imaging.
What products does James Hardie offer?
James Hardie is known for fibre cement and gypsum-based building materials used across residential and commercial construction.
Are PME and JHX part of the ASX 200?
Yes, both Pro Medicus and James Hardie Industries are listed in the ASX 200 index, reflecting their market capitalisation and relevance in their sectors.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.